Published by Frank Prenesti on 9th October 2024
(Sharecast News) - Life science investor Syncona said its portfolio company Purespring Therapeutics, which focuses on gene therapies for kidney diseases, had raised £80m in an oversubscribed financing.
URL: http://www.digitallook.com/dl/news/story/34611794/...